Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sloan, M. A.
Right arrow Articles by Price, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sloan, M. A.
Right arrow Articles by Price, T. R.
NEUROLOGY 1991;41:1358
© 1991 American Academy of Neurology

Occurrence of stroke associated with use/abuse of drugs

Michael A. Sloan, MD, Steven J. Kittner, MD, MPH, Daniele Rigamonti, MD and Thomas R. Price, MD

Stroke Epidemiology Unit (Drs. Sloan, Kittner, and Price), Department of Neurology (Drs. Sloan, Kittner, and Price), Department of Epidemiology and Preventive Medicine (Drs. Kittner and Price), and Division of Neurological Surgery, Department of Surgery (Dr. Rigamonti), University of Maryland School of Medicine, Baltimore, MD.

Ischemic and hemorrhagic stroke frequently occur in temporal association with use or abuse of illicit and over-the-counter (OTC) sympathomimetic drugs. However, little information is available on the proportion of strokes associated with use/abuse of drugs in specific hospital populations. Between September 1, 1988, and August 1, 1989, 167 of 178 stroke patients entered into the Maryland Stroke Data Bank were asked for a history of drug use or abuse. Information was incomplete in 51 of 167 (31%) patients due to neurologic deficit or lack of inquiry. Eleven of the remaining 116 cases (9.5%) were historically associated with drug use. Age range was 25 to 56 years (mean, 41 years). Stroke associated with drug use occurred in four of 62 (6%) cerebral infarcts, two of 28 (7%) intracerebral hemorrhages, and five of 26 (19%) subarachnoid hemorrhages (p = ns). Drugs included cocaine in five (45%), OTC sympathomimetics in three (27%), phencyclidine in two (18%), and heroin in one (9%).

Address correspondence and reprint requests to Dr. Michael A. Sloan, Department of Neurology, University of Maryland Hospital, 22 So. Greene Street, Baltimore, MD 21201.

Supported by National Institute of Neurological Disorders and Stroke Grant NS 16332-07. Dr. Kittner is the recipient of a Clinical Investigator Development Award (K08-NS01319-01) from the National Institute of Neurological Disorders and Stroke, Bethesda, MD.

Presented in part at the 42nd annual meeting of the American Academy of Neurology, Miami Beach, FL, May 1990.

Received October 29, 1990. Accepted for publication in final form February 13, 1991.




This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
B R Thanvi and S D Treadwell
Cannabis and stroke: is there a link?
Postgrad. Med. J., February 1, 2009; 85(1000): 80 - 83.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Cantu, A. Arauz, L. M. Murillo-Bonilla, M. Lopez, and F. Barinagarrementeria
Stroke Associated With Sympathomimetics Contained in Over-the-Counter Cough and Cold Drugs
Stroke, July 1, 2003; 34(7): 1667 - 1672.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. P. Broderick, C. M. Viscoli, T. Brott, W. N. Kernan, L. M. Brass, E. Feldmann, L. B. Morgenstern, J. L. Wilterdink, and R. I. Horwitz
Major Risk Factors for Aneurysmal Subarachnoid Hemorrhage in the Young Are Modifiable
Stroke, June 1, 2003; 34(6): 1375 - 1381.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. B. Goldstein, R. Adams, K. Becker, C. D. Furberg, P. B. Gorelick, G. Hademenos, M. Hill, G. Howard, V. J. Howard, B. Jacobs, et al.
Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association
Circulation, January 2, 2001; 103(1): 163 - 182.
[Full Text] [PDF]


Home page
StrokeHome page
L. B. Goldstein, R. Adams, K. Becker, C. D. Furberg, P. B. Gorelick, G. Hademenos, M. Hill, G. Howard, V. J. Howard, B. Jacobs, et al.
Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association
Stroke, January 1, 2001; 32(1): 280 - 299.
[Full Text] [PDF]


Home page
Arch NeurolHome page
H. P. Adams Jr, L. J. Kappelle, J. Biller, D. L. Gordon, B. B. Love, F. Gomez, and M. Heffner
Ischemic Stroke in Young Adults: Experience in 329 Patients Enrolled in the Iowa Registry of Stroke in Young Adults
Arch Neurol, May 1, 1995; 52(5): 491 - 495.
[Abstract] [PDF]


Home page
NEJMHome page
J. F. Tapia and J. M. Schumacher
Case 27-1993- A 32-Year-Old Man with the Sudden Onset of a Right-Sided Headache and Left Hemiplagia and Hemianesthesia
N. Engl. J. Med., July 8, 1993; 329(2): 117 - 124.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by AAN Enterprises, Inc.